MACCHINI, MARINA
 Distribuzione geografica
Continente #
NA - Nord America 2.183
EU - Europa 1.878
AS - Asia 994
AF - Africa 142
SA - Sud America 6
OC - Oceania 2
Totale 5.205
Nazione #
US - Stati Uniti d'America 2.176
GB - Regno Unito 475
IT - Italia 365
CN - Cina 336
VN - Vietnam 323
SE - Svezia 285
SG - Singapore 204
DE - Germania 201
CH - Svizzera 108
IN - India 95
IE - Irlanda 91
UA - Ucraina 89
RU - Federazione Russa 72
FR - Francia 71
ZA - Sudafrica 45
TG - Togo 41
EE - Estonia 35
NG - Nigeria 32
BG - Bulgaria 20
BE - Belgio 16
JO - Giordania 15
FI - Finlandia 14
CI - Costa d'Avorio 13
AT - Austria 8
IR - Iran 7
NL - Olanda 6
SC - Seychelles 6
HR - Croazia 5
ID - Indonesia 4
NI - Nicaragua 4
PL - Polonia 4
CA - Canada 3
ES - Italia 3
GR - Grecia 3
PT - Portogallo 3
AU - Australia 2
BR - Brasile 2
CL - Cile 2
CM - Camerun 2
LB - Libano 2
SK - Slovacchia (Repubblica Slovacca) 2
TR - Turchia 2
CZ - Repubblica Ceca 1
DZ - Algeria 1
EC - Ecuador 1
EG - Egitto 1
HK - Hong Kong 1
IL - Israele 1
JP - Giappone 1
MU - Mauritius 1
PE - Perù 1
RO - Romania 1
SA - Arabia Saudita 1
TW - Taiwan 1
UZ - Uzbekistan 1
Totale 5.205
Città #
Southend 437
Chandler 237
Fairfield 208
Dong Ket 204
Ashburn 176
Singapore 176
Princeton 118
Houston 106
Bern 105
Wilmington 101
Santa Clara 93
Ann Arbor 91
Dublin 91
New York 86
Woodbridge 80
Seattle 69
Boardman 59
Cambridge 57
Jacksonville 56
Nanjing 49
Westminster 47
Bologna 46
Padova 45
Lomé 41
Medford 35
Abeokuta 32
Turin 31
Berlin 30
Shenyang 29
Saint Petersburg 24
Florence 22
Jinan 22
Mülheim 20
Sofia 20
Dearborn 19
Hebei 19
Milan 19
Beijing 18
Changsha 16
Los Angeles 16
Amman 15
Rome 15
Tianjin 15
Helsinki 14
Nanchang 14
Abidjan 13
Fremont 13
Redwood City 13
Brussels 12
San Diego 12
Falls Church 11
Jiaxing 11
Taiyuan 11
Des Moines 10
Ravenna 10
San Venanzo 9
Guangzhou 7
Haikou 7
Hangzhou 7
Olalla 7
Kunming 6
Mahé 6
Norwalk 6
Torino 6
Vienna 6
Zhengzhou 6
Monmouth Junction 5
Shanghai 5
Taizhou 5
Ardabil 4
Bremen 4
Bühl 4
Groningen 4
Hefei 4
Jakarta 4
Kiev 4
Lanzhou 4
Leawood 4
Managua 4
Mumbai 4
Parma 4
Phoenix 4
Xi'an 4
Cesena 3
Forlì 3
Frankfurt am Main 3
Kuban 3
Mountain View 3
Ningbo 3
Shenzhen 3
Bari 2
Bastiglia 2
Buffalo 2
Casalecchio Di Reno 2
Chicago 2
Cinisello Balsamo 2
Costa Mesa 2
Dongguan 2
Empoli 2
Fort Worth 2
Totale 3.524
Nome #
Follow-up del cancro del pancreas esocrino 271
Characterization of pancreatic ductal adenocarcinoma patients using whole-transcriptome sequencing and copy number analysis by SNPs array techniques. 187
Characterization of pancreatic ductal adenocarcinoma using whole transcriptome sequencing and copy number analysis by single-nucleotide polymorphism array 186
Antiprotease strategy in combination with gemcitabine as a putative novel therapeutic approach for pancreatic cancer treatment 181
Antiprotease strategy in pancreatic cancer treatment: emergence from a preclinical study. 171
Chemotherapy followed by chemoradiotherapy in locally advanced pancreatic cancer:A literature review and report of two cases 169
Comparing recist and Choi’s criteria to evaluate radiological response to chemotherapy in patients with advanced pancreatic cancer 156
Venous thromboembolism and port-related thrombosis in metastatic colorectal cancer patients: a monocenter experience. 136
Clinical impact of nonselective beta-blockers on survival in patients with pancreatic cancer- revival of well known drugs? 133
Neoadjuvant therapy for resectable pancreatic adenocarcinoma: An interim report of a prospective randomized study 132
Comparing RECIST and Choi's Criteria After Neoadjuvant Chemoradiotherapy in Patients with Resectable Pancreatic Cancer 129
GemOx and Ovarian Pancreatic Cancer Metastasis (PC) 121
Advanced pancreatic cancer (APC) A monocenter experience in 53 patients: is it possible a second line treatment? 120
CIRCULATING METALLOPROTEINASE-3 AND TISSUE INHIBITOR OF METALLOPROTEINASE-2 IN PATIENTS WITH DUCTAL PANCREATIC NEOPLASMS 117
State of the art biological therapies in pancreatic cancer 114
Hedgehog Signaling: from the Cuirass to the Heart of Pancreatic Cancer 111
β2 Adrenergic-Neurotrophin Feedforward Loop Promotes Pancreatic Cancer 108
Retroperitoneal lymphangioma: A report of 2 cases and a review of the literature regarding the differential diagnoses of retroperitoneal cystic masses 107
Metastatic pancreatic cancer: is gemcitabine still the best standard treatment? 106
Comparing RECIST and Choi’s Criteria to Evaluate Radiological Response to Chemotherapy in Patients with Advanced Pancreatic Cancer 106
Preoperatory Gemcitabine and Oxaliplatin in a patient with ovarian metastasis from pancreatic cystadenocarcinoma 103
Long-Term Survival After Pancreaticoduodenectomy for Pancreatic Ductal Adenocarcinoma. Case Report 101
Role of adjuvant chemoradiotherapy (CRT) and chemotherapy alone in pancreatic cancer: experience in 25 patients. 99
Advanced pancreatic cancer (apc); a Monocenter experience in 53 patients. It is possible a second line treatment? 99
Useful of Choi’s criteria after neoadjuvant chemoradiotherapy in patients with resectable pancreatic cancer. 99
Gemox in combination witherlotinib (E) in pancreatic cancer (PC). 99
Prognostic factors for recurrence in resected pancreatic adenocarcinoma: a single center experience 97
The Protease Inhibitor Gabexate Mesylate Reduces Invasiveness and Angiogenesis in Pancreatic Cancer Cell Lines, Enhancing Gemcitabine Action 93
Comparing RECIST and Choi’s Criteria to Evaluate Radiological Response to Chemotherapy in Patients with Resectable and Advanced Pancreatic Cancer. 92
GEMOX AS FIRST-LINE CHEMOTHERAPY IN ADVANCED PANCREATIC CANCER (APC): A MONOINSTITUTIONAL EXPERIENCE 92
Prognostic factors in resected pancreatic cancer:a single centre experience 90
The follow-up issues: from the necessity to the opportunity 88
Germinal BRCA1-2 pathogenic variants (gBRCA1-2pv) and pancreatic cancer: epidemiology of an Italian patient cohort 87
Neoadjuvant therapy for resectable pancreatic adenocarcinoma: an interim report of a prospective controlled randomized study. 86
Erratum: β2 Adrenergic-Neurotrophin Feedforward Loop Promotes Pancreatic Cancer (Cancer Cell (2018) 33(1) (75–90.e7), (S153561081730510X) (10.1016/j.ccell.2017.11.007)) 86
Whole-transcriptome paired-end sequencing and the pancreatic cancer genetic landscape 84
Massively Parallel Sequencing Analysis of Genetic Alterations Carried by Pancreatic Adenocarcinoma 83
Neoadjuvant Therapy for Resectable Pancreatic Adenocarcinoma: An Interim Report of a Prospective Controlled Randomized Study 83
Locally Advanced Pancreatic Cancer: Is It Possible Pancreatic Resection? A Case Report 80
Whole Transcriptome Sequencing Reveals Molecular Prognostic Markers in Pancreatic Adenocarcinoma 79
SNP-Array High Resolution Cytogenetic Analysis of Resectable and Advanced Pancreatic Cancer 71
New WHO classification for pancreatic endocrine tumours: is time to leave the previous one 71
Resection Margin Involvement in Pancreaticoduodenectomy. A Single Centre Experience 67
Whole Transcriptome Sequencing Reveals Somatic HMGCR Mutation in a Case of Pancreatic Adenocarcinoma with Long-Term Therapy Response 67
Role of CA 19-9 Concentration as an Independent Prognostic Factor in Unresectable Pancreatic Ductal Adenocarcinoma (PDCA) Treated with GemOx 66
Whole genome discovery of genetic alterations in resectable and advanced pancreatic cancer. 64
Massively Parallel Sequencing Analysis of Genetic Alterations Carried by Pancreatic Adenocarcinoma 62
Chemotherapy toxicity and activity in patients with pancreatic ductal adenocarcinoma and germline BRCA1-2 pathogenic variants (gBRCA1-2pv): a multicenter survey 60
Whole genome discovery of genetic alterations carried by pancreatic adenocarcinoma 59
Germinal BRCA1-2 pathogenic variants (gBRCA1-2pv) and pancreatic cancer: epidemiology of an Italian patient cohort 38
Second-line therapy in pancreatic ductal adenocarcinoma (PDAC) patients with germline BRCA1-2 pathogenic variants (gBRCA1-2pv) 36
Guideline Application in Real world: multi-Institutional Based survey of Adjuvant and first-Line pancreatic Ductal adenocarcinoma treatment in Italy. Primary analysis of the GARIBALDI survey 16
Totale 5.358
Categoria #
all - tutte 12.907
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.907


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020628 0 0 0 0 62 82 90 99 120 64 50 61
2020/2021775 126 19 14 18 11 35 15 44 69 30 32 362
2021/2022994 80 44 30 70 89 51 13 57 38 107 240 175
2022/20231.238 105 173 69 133 80 102 13 84 169 51 135 124
2023/2024405 26 44 10 37 34 135 17 31 9 21 23 18
2024/2025533 59 136 98 66 174 0 0 0 0 0 0 0
Totale 5.358